M. May Zhu


e: mmz@c-m.com

p: 617-951-3055

f: 617-951-3927




  • Suffolk University Law School (J.D. in Intellectual Property Law Concentration and Patent Law Specialization, cum laude, 2012)

  • University of Alberta (M.S. in Organic Chemistry, 2003)

  • Peking University, Health Science Center (formerly Beijing Medical University) (M.S. in Medicinal Chemistry, 2000)

  • Peking University, Health Science Center (formerly Beijing Medical University) (B.S. in Pharmaceutical Chemistry, 1997)

Bar Admissions

  • Massachusetts

  • U.S. Patent and Trademark Office

Bar Admissions

  • Fluent in Mandarin Chinese

May is an associate with the firm. Her practice focuses on patent prosecution and client counseling in the fields of organic chemistry, pharmaceuticals, diagnostics, medical science, polymer chemistry, and nanotechnology.

Prior to joining Cesari & McKenna, May worked as a research chemist and patent assistant for nearly a decade at Novartis Institutes for Biomedical Research (NIBR), Cambridge, MA. She has extensive scientific experience with small molecule drugs and their development in multiple disease areas, such as cardiovascular diseases, diabetes, and cancer. May is a co-inventor in four US patent applications filed by NIBR, titled “Novel Formats for Organic Compounds for Use in RNA Interference,” “Organic Compositions to Treat Hepcidin-Related Diseases,” “3’ End Caps for RNAi Agents for Use in RNA Interference,” and “Organic Compounds to Treat Hepatitis B Virus.”  At NIBR, she also co-authored a scientific article: Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors, Journal of Medicinal Chemistry, 2010, 53 (15), 5400.

While at Suffolk University Law School, May was a lead article editor for the Journal of High Technology Law and had authored one book note, reviewing Qasim Chaudhry, et. al, Nanotechnologies in Food and analyzing regulations on the use of nanotechnologies in foods in the United States and European Union (Fall, 2010), and one article, “Patent Infringement through Foreign Offer for Domestic Sale: Transocean v. Maersk,” (Fall, 2012).


During her undergraduate and graduate study at Peking University, May earned “Best Bachelor Thesis Award,” “China-Japan Medicine and Pharmacy Scholarship,” and “Excellent Academic Award;” and her master thesis “Novel P45017α Inhibitors: 17-(2’-Oxazolyl) and 17-(2’-Thiazolyl) Androstene Derivatives” was published in Steroids, 2003, 68, 603. Subsequently, May attended the graduate school at University of Alberta, where she completed another master degree and thesis “Effect of Additives on the Stereochemical Integrity and Reactivity of α-Alkoxycarbonyl Alkenylcopper Intermediates. Optimal Conditions for the Isomerically Pure Tetrasubstituted Alkenes,” which was published in Journal of Organic Chemistry, 2003, 68, 6066.

  • American Bar Association

  • American Intellectual Property Law Association

  • American Chemical Society